John H. Strickler, Akihito Kawazoe, Jian Li, Lin Shen, Hua Fang, Martha Raluca Neagu Aristide, Athanasios Vasilopoulos, Yunxia Sui, Rabih Saab, Carla Biesdorf de Almeida, Kanwal Pratap Singh Raghav. "Telisotuzumab adizutecan (ABBV-400; Temab-A) monotherapy vs trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer with increased c-Met protein expression: An open-label, randomized, phase 3 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3635